• Jobs
  • Startups
  • Hire
LoginSign up

Role description

Associate Director, Statistical Programming

MBX Biosciences logoMBX Biosciences
TypeFull-time
WorkplaceHybrid
SeniorityDirector / Executive
LocationBurlington, MA
Posted8/17/2026
Data

Working with Us

MBX Biosciences is a clinical-stage biopharmaceutical company headquartered in Carmel, Indiana, with a secondary office in Burlington, MA.  Our mission is to transform the lives of people impacted by endocrine and metabolic disorders through our novel precision peptides.

Leveraging our proprietary Precision Endocrine Peptides (PEPs)™ platform, we are pioneering technology designed to overcome key limitations of existing therapies and enhance efficacy, tolerability, safety and convenience. Our team is advancing a pipeline of novel candidates with clinically validated targets, established endpoints for regulatory approval, and strong market potential.

Our pipeline includes canvuparatide (MBX 2109) for the treatment of chronic hypoparathyroidism, currently preparing for Phase 3 development, and a growing obesity portfolio that includes MBX 4291 in Phase 1 development, MBX 5765, a next-generation amycretin prodrug designed for once-monthly dosing, as well as MBX 6180, a GLP/GIP/GCGR triple agonist prodrug for once monthly dosing; all of which optimize our PEP platform.

If you’re passionate about advancing innovative treatments for patients and shaping the future of precision peptide therapeutics, this is your chance to make a real impact alongside a fast-paced, growing, mission-driven team.  To learn more, visit our website mbxbio.com and follow us on LinkedIn.

Position Summary

MBX is seeking an Associate Director, Statistical Programming to lead and contribute to  statistical programming and analysis of clinical trial data. This role is integral to the design, execution, and interpretation of analyses for clinical trials and related research activities. The Associate Director will ensure the quality and accuracy of statistical deliverables, oversee external vendor performance, and contribute to internal process improvements, including maintaining and expanding SAS macros, R workflows, and clinical data repositories.

What You’ll Do

  • Oversee and execute statistical programming deliverables for planned analyses, including study monitoring, data reviews, clinical study reports, data integrations, and rapid responses to regulatory queries across multiple compounds and studies.
  • Lead global submission activities, acting as a programming functional and technical expert to support submission strategy planning and regulatory communications; ensure all programming deliverables meet timelines, quality standards, and regulatory expectations (eg, ICH, FDA, EMA).
  • Manage CROs and contractors to ensure compliance, high-quality deliverables, adherence to timelines, and budget alignment.
  • Develop and validate reproducible, well-documented statistical programs to produce outputs for integrated scientific reports of clinical trial results, ensuring adherence to protocols and Statistical Analysis Plans (SAPs), and regulatory reporting conventions.
  • Maintain and enhance the internal SAS macro library and database.
  • Provide statistical programming input for SAPs, publications, scientific presentations, regulatory submissions, and promotional materials.
  • Review Case Report Forms (CRFs), CRF annotations, SAPs, Table, Listing, and Figure (TLF) shells, TLF outputs, dataset specifications (SDTM and ADaM).
  • Serve as a lead for statistical programming within study teams, effectively communicating statistical and programming issues to development teams.
  • Contribute to the development of programming standards, macros, SOPs, and process improvements within the Biometrics function
  • Other responsibilities as assigned.

What You Bring

  • 8+ years of statistical programming experience in the biotech or pharmaceutical industry, with a preference for expertise in endocrine and metabolic disorders.
  • Advanced degree (PhD, MS,  etc.) in life sciences, biostatistics, mathematics, computer science, or a related field preferred.
  • Proficient in SAS programming (e.g., Base SAS, SAS/Stat, SAS/Graph, SAS macros, ODS) with a solid understanding of database systems
  • Experience with R and Python preferred for advanced data visualization and analysis.
  • Extensive experience with CDISC standards (SDTM, ADaM, define.xml) and electronic submissions (eSub) under eCTD specifications.
  • Proven ability to lead programming activities and provide oversight of CRO deliverables.
  • Strong analytical, organizational, and communication skills, with a keen eye for detail and the ability to manage multiple priorities in a dynamic, fast-paced environment.
  • Demonstrated leadership in cross-functional teams, experience with global submissions, and knowledge of  database management.

Travel & In Office Presence

You will be expected to travel periodically based on the needs of the business, including attendance at Together Weeks, Together Days, and functional meetings as requested by the team. Employees are expected to work on hybrid schedules, consistent with local office practices and the terms of the companies in office policy as in effect from time to time.

EEO Statement:

MBX Biosciences is an Equal Opportunity Employer and is committed to treating all applicants fairly without discrimination. We welcome applications from all individuals, regardless of race, national origin, gender, age, physical characteristics, social origin, disability, union membership, religion, family status, pregnancy, sexual orientation, gender identity, gender expression or any unlawful criterion under applicable law.  

Relevant archetypes

Apply on mbxbio.com
Save

Company info

MBX Biosciences logo

MBX Biosciences

MBX Biosciences, Inc. is a clinical stage biopharmaceutical company pioneering investigational Precision Endocrine Peptides (PEPs™). PEPs are designed to overcome key limitations of native peptide therapeutics to deliver superior pharmacologic properties. MBX is advancing a pipeline of PEP candidates to address the unmet needs of people with endocrine disorders. The company’s lead product candidate, MBX 2109 for the treatment of hypoparathyroidism, is currently in a Phase 1 clinical trial. Members of MBX’s leadership team have collaborated over several decades on the discovery, development, and commercialization of highly successful endocrine therapeutics including Forteo® and Humalog®. The company is supported by leading life science investors including Frazier Life Sciences, New Enterprise Associates and OrbiMed.

Series C
Founded2019
HQCarmel, United States
Size51–200 employees
Unlock human wisdom
ThesisTermsPrivacy
Industry
Biotechnology Research
Funding
  • Series C · $34.6M · Aug 5, 2024
Investors
Frazier Healthcare PartnersNew Enterprise AssociatesTwilight Venture PartnersOrbiMedBioCrossroads
Tech stackmicrosoft-project, microsoft-sharepoint, medidata, smartsheet, microsoft-active-directory, quality-unit, workspace, microsoft-powerpoint, veeva, microsoft-teams

Claim mbxbio.com

Work at mbxbio.com? Sign in to claim this org and manage its profile.

© 2026 Saywise Inc.